💼Notice of NIH Meeting on TB Research Grant Applications
The Department of Health and Human Services announces a closed meeting by the National Institute of Allergy and Infectious Diseases to review grant applications related to tuberculosis research. The meeting is not open to the public and focuses on evaluating confidential information, including trade secrets and personal data associated with the applications.
Learn More🧬NIH Notice of Closed Meeting on Grant Proposals for Health Research
The Department of Health and Human Services announces a closed meeting of the National Institute of Allergy and Infectious Diseases to evaluate grant proposals related to neuroHIV research. The meeting emphasizes the confidentiality of discussed materials and includes details about the committee, its agenda, and contact information for inquiries.
Learn More🏥NIH Notice
The National Institutes of Health announces a closed meeting for the National Institute of Allergy and Infectious Diseases to evaluate contract proposals for developing diagnostics for Mycoplasma genitalium infection. The meeting focuses on contract discussions that may include sensitive trade secrets and personal information, reflecting the importance of confidentiality in health-related innovations.
Learn More💰NIH Meeting Notice for Grant Review in Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases announces a closed meeting to evaluate grant applications, as required by the Federal Advisory Committee Act. This meeting will involve confidential discussions regarding potentially patentable materials and trade secrets, providing essential insights for stakeholders in the health research community. Interested parties are encouraged to submit comments.
Learn More💰NIH Announces Meeting to Review Grant Applications for Health Research
The National Institutes of Health has announced a closed meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel to review and evaluate grant applications. This meeting, taking place from May 5-7, 2025, is crucial as it involves discussions that could impact confidential trade secrets and commercial properties.
Learn More💰NIH Notice
The Department of Health and Human Services announces closed meetings by the National Institutes of Health to evaluate grant applications related to allergy and infectious diseases. These meetings are crucial for organizations seeking funding opportunities to advance research in these fields. Contact information for further inquiries is provided.
Learn More💉Notice of NIH Closed Meeting for Grant Evaluation in Allergy Research
The Department of Health and Human Services announces a closed meeting by the National Institute of Allergy and Infectious Diseases to review grant applications related to microbiology and infectious diseases. The meeting will evaluate proposals that may include confidential information or trade secrets. A video-assisted format will be used for this evaluation meeting.
Learn More💵NIH Meeting Notice for Grant Review in Allergy & Infectious Diseases
The Department of Health and Human Services announces a closed meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel to review grant applications. The meeting will evaluate submissions related to healthcare research while ensuring confidentiality of sensitive data. The format will be video assisted, and interested parties can contact the designated officer for details.
Learn More🏥Closed Meeting Notice - National Institutes of Health February 2024
The National Institute of Allergy and Infectious Diseases has announced a closed meeting to review contract proposals for vaccine adjuvant development. The meeting will take place on February 3-4, 2024, and focuses on confidentiality regarding trade secrets and personal information. It is not open to the public and serves an administrative purpose.
Learn More🏥NIH Meeting Notice for Grant Applications in Infectious Diseases
The National Institute of Allergy and Infectious Diseases announces a closed meeting to review grant applications, which may involve confidential information pertaining to health research initiatives. The meeting will occur via video and is primarily focused on evaluating strategies to eliminate HIV proteins.
Learn More